X-linked Hypophosphatemia Market is Segmented By Therapeutics (Oral Medications, Injectable Medications, Gene Therapies), By End Users (Hospitals, Specialty Clinics, Homecare Settings), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Billion) for the above-mentioned segments.